Lyra Therapeutics Inc (LYRA)
Lyra Therapeutics Market Cap: 20.87M for May 22, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 22, 2024 | 20.87M |
May 21, 2024 | 21.67M |
May 20, 2024 | 22.74M |
May 17, 2024 | 23.35M |
May 16, 2024 | 22.41M |
May 15, 2024 | 21.69M |
May 14, 2024 | 22.68M |
May 13, 2024 | 22.11M |
May 10, 2024 | 22.71M |
May 09, 2024 | 23.56M |
May 08, 2024 | 23.76M |
May 07, 2024 | 25.61M |
May 06, 2024 | 31.79M |
May 03, 2024 | 245.69M |
May 02, 2024 | 282.27M |
May 01, 2024 | 320.07M |
April 30, 2024 | 314.58M |
April 29, 2024 | 288.36M |
April 26, 2024 | 287.75M |
April 25, 2024 | 315.19M |
April 24, 2024 | 318.85M |
April 23, 2024 | 317.63M |
April 22, 2024 | 317.63M |
April 19, 2024 | 316.41M |
April 18, 2024 | 328.60M |
Date | Value |
---|---|
April 17, 2024 | 329.52M |
April 16, 2024 | 329.21M |
April 15, 2024 | 321.28M |
April 12, 2024 | 321.89M |
April 11, 2024 | 331.65M |
April 10, 2024 | 320.07M |
April 09, 2024 | 319.46M |
April 08, 2024 | 310.92M |
April 05, 2024 | 306.04M |
April 04, 2024 | 321.89M |
April 03, 2024 | 332.87M |
April 02, 2024 | 342.01M |
April 01, 2024 | 381.03M |
March 28, 2024 | 371.60M |
March 27, 2024 | 390.12M |
March 26, 2024 | 366.23M |
March 25, 2024 | 368.02M |
March 22, 2024 | 372.80M |
March 21, 2024 | 362.64M |
March 20, 2024 | 362.64M |
March 19, 2024 | 360.85M |
March 18, 2024 | 344.72M |
March 15, 2024 | 354.28M |
March 14, 2024 | 342.33M |
March 13, 2024 | 382.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Integra Lifesciences Holdings Corp | 2.216B |
Perspective Therapeutics Inc | 927.72M |
Electromed Inc | 140.74M |
Xtant Medical Holdings Inc | 101.57M |
Asensus Surgical Inc | 66.56M |
Market Cap Related Metrics
PS Ratio | 11.52 |
Price to Book Value | 0.2693 |
Price | 0.3423 |
Earnings Yield | -350.6% |